A Food Effect Study of IM156
Latest Information Update: 12 Apr 2022
At a glance
- Drugs IM 156 (Primary)
- Indications Cancer; Idiopathic pulmonary fibrosis
- Focus Adverse reactions
- Sponsors ImmunoMet Therapeutics
Most Recent Events
- 12 Apr 2022 New trial record